...
首页> 外文期刊>Acta biomaterialia >Tailored design of multifunctional and programmable pH-responsive self-assembling polypeptides as drug delivery nanocarrier for cancer therapy
【24h】

Tailored design of multifunctional and programmable pH-responsive self-assembling polypeptides as drug delivery nanocarrier for cancer therapy

机译:多功能和可编程pH响应自组装多肽的量身定制设计作为癌症治疗的药物递送纳米载体

获取原文
获取原文并翻译 | 示例

摘要

Breast cancer has become the second leading cause of cancer-related mortality in female wherein more than 90% of breast cancer-related death results from cancer metastasis to distant organs at advanced stage. The purpose of this study is to develop biodegradable nanoparticles composed of natural polypeptides and calcium phosphate (CaP) with sequential pH-responsivity to tumor microenvironments for active targeted drug delivery. Two different amphiphilic copolymers, poly(ethylene glycol)(3400)-aconityl linkage-poly(L-glutamic acid)(15)-poly(L-histidine)(10)-poly(L-leucine)(10) and LyP1-poly(ethylene glycol)(1100)-poly(L-glutamic acid)(15)-poly(L-histidine)(10)-poly(L-leucine)(10), were exploited to self-assemble into micelles in aqueous phase. The bio-stable nanoparticles provide three distinct functional domains: the anionic PGlu shell for CaP mineralization, the protonation of PHis segment for facilitating anticancer drug release at target site, and the hydrophobic core of PLeu for encapsulation of anticancer drugs. Furthermore, the hydrated PEG outer corona is used for prolonging circulation time, while the active targeting ligand, LyP-1, is served to bind to breast cancer cells and lymphatic endothelial cells in tumor for inhibiting metastasis. Mineralized DOX-loaded nanoparticles (M-DOX NPs) efficiently prevent the drug leakage at physiological pH value and facilitate the encapsulated drug release at acidic condition when compared to DOX-loaded nanoparticles (DOX NPs). M-DOX NPs with LyP-1 targeting ligand effectively accumulated in MDA-MB-231 breast cancer cells. The inhibition effect on cell proliferation also enhances with time, illustrating the prominent anti-tumor efficacy. Moreover, the in vitro metastatic inhibition model shows the profound inhibition effect of inhibitory nanoparticles. In brief, this self-assembling peptide-based drug delivery nanocarrier with multifunctionality and programmable pH-sensitivity is of great promise and potential for anti-cancer therapy.
机译:乳腺癌已成为癌症相关死亡率的第二个主要原因,其中超过90%的乳腺癌相关的死亡导致癌症转移到晚期患者的遥远器官。本研究的目的是开发由天然多肽和磷酸钙(盖子)组成的可生物降解的纳米颗粒,其对肿瘤微环境的顺序pH-响应性用于活性靶向药物递送。两种不同的两亲性共聚物,聚(乙二醇)(3400) - AconityL键合 - 聚(L-谷氨酸)(15) - 聚(L-组氨酸)(10) - 聚(L-亮氨酸)(10)和LYP1-聚(乙二醇)(1100) - 聚(L-谷氨酸)(15) - 聚(L-组氨酸)(10) - 聚(L-亮氨酸)(10)被利用以自组装成水性的胶束阶段。生物稳定的纳米颗粒提供三个不同的功能域:阴离子PGLU壳用于封闭矿化,PHIS段的质子化,以促进靶位部位的抗癌药物释放,以及Pleu的疏水核心用于封装抗癌药物。此外,水合的PEG外部电晕用于延长循环时间,而活性靶向配体,LYP-1用于结合肿瘤中的乳腺癌细胞和淋巴内皮细胞,用于抑制转移。矿化的Dox加载的纳米颗粒(M-DOX NPS)有效地防止生理pH值的药物泄漏,并在与DOX的纳米颗粒(DOX NPS)相比时促进酸性条件下的包封药物释放。 M-DOX NPS具有乳清乳型配体,有效累积在MDA-MB-231乳腺癌细胞中。对细胞增殖的抑制作用也随着时间的推移而增强,说明了突出的抗肿瘤疗效。此外,体外转移性抑制模型显示抑制纳米粒子的深吸抑制作用。简而言之,这种具有多功能性和可编程pH敏感性的基于肽的药物递送纳米载体具有很大的承诺和抗癌治疗的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号